Literature DB >> 8050096

Synthesis of KDN-lactotetraosylceramide, KDN-neolactotetraosylceramide, and KDN-Lewis X ganglioside.

T Terada1, M Kiso, A Hasegawa.   

Abstract

Analogues of sialyl-lactotetraosylceramide, sialyl-neolactotetraosylceramide, and sialyl Lewis X ganglioside, in which the N-acetylneuraminic acid residue is replaced by a 3-deoxy-D-glycero-D-galacto-2-nonulopyranosylonic acid (KDN) unit, have been synthesized. Methyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-alpha-D-galacto-2- nonulopyranosylonate)-(2-->3)-2,4,6-tri-O-benzoyl-1-thio-beta-D- galactopyranoside (4) was prepared from 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-alpha-D-galacto-2- nonulopyranosylonate)-(2-->3)-6-O-benzoyl-beta-D-galactopyranoside , via O-benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with trimethyl(methylthio)silane. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-beta-D-glucopyranosyl)-(1-->3)- O- (2,4,6-tri-O-benzyl-beta-D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl- beta- D-glucopyranoside (5) or of 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-beta-D-glucopyranosyl)-(1-->3)-O- (2,4,6-tri-O-benzyl-beta-D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl- beta- D-glucopyranoside, prepared from 5 via O-benzylation and reductive opening of the benzylidene acetal ring, with 4 as a donor gave the corresponding pentasaccharides 9 and 13 in good yields. In the same way, 4 was reacted with 2-(trimethylsilyl)ethyl O-(2,3,4-tri-O-benzyl-alpha-L-fucopyranosyl)-(1-->3)-O-(2-acetamido-6- O-benzyl-2-deoxy-beta-D-glucopyranosyl)-(1-->3)-O-(2,4,6-tri-O-benzyl-be ta- D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside to yield the hexasaccharide 17. These three oligosaccharides 9, 13, and 17 were converted via reductive removal of the benzyl groups and benzylidene group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and subsequent reaction with trichloroacetonitrile, into the corresponding trichloroacetimidates 12, 16, and 20, respectively. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with 12, 16, and 20 in the presence of boron trifluoride etherate afforded the expected beta-glycosides, which were transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target gangliosides in high yields.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050096     DOI: 10.1016/0008-6215(94)84058-x

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  5 in total

Review 1.  KDN (deaminated neuraminic acid): dreamful past and exciting future of the newest member of the sialic acid family.

Authors:  Sadako Inoue; Ken Kitajima
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

2.  A General Chemoenzymatic Strategy for the Synthesis of Glycosphingolipids.

Authors:  Yunpeng Liu; Liuqing Wen; Lei Li; Madhusudhan Reddy Gadi; Wanyi Guan; Kenneth Huang; Zhongying Xiao; Mohui Wei; Cheng Ma; Qing Zhang; Hai Yu; Xi Chen; Peng George Wang; Junqiang Fang
Journal:  European J Org Chem       Date:  2016-08-16

3.  Synthetic sulfogalactosylceramide (sulfatide) and its use for the mass spectrometric quantitative urinary determination in metachromatic leukodystrophies.

Authors:  Yanli Cui; Benoit Colsch; Carlos Afonso; Carlos Alonso; Nicole Baumann; Jean-Claude Tabet; Jean-Maurice Mallet; Yongmin Zhang
Journal:  Glycoconj J       Date:  2007-08-15       Impact factor: 2.916

4.  First synthesis of two deoxy Lewis(x) pentaosyl glycosphingolipids.

Authors:  Yun Luo; Chafika Gourmala; Dengxiang Dong; Florent Barbault; Botao Fan; Yongzhou Hu; Yongmin Zhang
Journal:  Glycoconj J       Date:  2007-11-01       Impact factor: 2.916

5.  A one pot synthesis of mono- and di-lactosyl sphingosines.

Authors:  Y Zhang; T Toyokuni; F Ruan; S I Hakomori
Journal:  Glycoconj J       Date:  2001-07       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.